These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 2378846)

  • 21. Intravitreal bevacizumab for incontinentia pigmenti.
    Shah PK; Bachu S; Narendran V; Kalpana N; David J; Srinivas CR
    J Pediatr Ophthalmol Strabismus; 2013 Oct; 50 Online():e52-4. PubMed ID: 25313552
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Subungual tumors in incontinentia pigmenti.
    Simmons DA; Kegel MF; Scher RK; Hines YC
    Arch Dermatol; 1986 Dec; 122(12):1431-4. PubMed ID: 3789779
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Macular vasculopathy and its evolution in incontinentia pigmenti.
    Goldberg MF
    Trans Am Ophthalmol Soc; 1998; 96():55-65; discussion 65-72. PubMed ID: 10360282
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Incontinentia pigmenti. Apropos of a case].
    Turut P; Dumont P; Piussan C; Madelain J
    Bull Soc Ophtalmol Fr; 1987 Oct; 87(10):1139-40, 1143. PubMed ID: 3449288
    [No Abstract]   [Full Text] [Related]  

  • 25. The Prevalence of Retinal Disease and Associated CNS Disease in Young Patients with Incontinentia Pigmenti.
    Danford ID; Scruggs BA; Capone A; Trese MT; Drenser KA; Thanos A; Nudleman E; Amphornphruet A; Tipsuriyaporn B; Hubbard GB; Ells A; Harper CA; Goldstein J; Calvo C; Wallace-Carrete C; Berry D; Chang E; Leishman L; Shapiro M; Blair M; Mikhail M; Shields CL; Schwendeman R; Yonekawa Y; Gupta MP; Orlin A; Prakhunhungsit S; Mukai S; Berrocal A; Hartnett ME; Campbell JP
    Ophthalmol Retina; 2022 Dec; 6(12):1113-1121. PubMed ID: 35691580
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SUCCESSFUL TREATMENT OF REFRACTORY PROLIFERATIVE RETINOPATHY OF INCONTINENTIA PIGMENTI BY INTRAVITREAL RANIBIZUMAB AS ADJUNCT THERAPY IN A 4-YEAR-OLD CHILD.
    Ho M; Yip WWK; Chan VCK; Young AL
    Retin Cases Brief Rep; 2017 Fall; 11(4):352-355. PubMed ID: 27472514
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early management of sight threatening retinopathy in incontinentia pigmenti.
    Michel S; Reynaud C; Daruich A; Hadj-Rabia S; Bremond-Gignac D; Bodemer C; Robert MP
    Orphanet J Rare Dis; 2020 Aug; 15(1):223. PubMed ID: 32854719
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incontinentia pigmenti and Behçet's syndrome: an unusual combination.
    Menni S; Piccinno R; Biolchini A; Delle Piane RM; Bardare M
    Acta Derm Venereol; 1986; 66(4):351-4. PubMed ID: 2430411
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Revascularization After Intravitreal Bevacizumab and Laser Therapy of Bilateral Retinal Vascular Occlusions in Incontinentia Pigmenti (Bloch-Sulzberger Syndrome).
    Cernichiaro-Espinosa LA; Patel NA; Bauer MS; Negron CI; Fallas B; Pogrebniak A; Berrocal AM
    Ophthalmic Surg Lasers Imaging Retina; 2019 Feb; 50(2):e33-e37. PubMed ID: 30768227
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unilateral Retinopathy from Incontinentia Pigmenti.
    Ramachandran N; Benson MD; Grewal PS
    Ophthalmol Retina; 2024 Sep; 8(9):e8. PubMed ID: 38430079
    [No Abstract]   [Full Text] [Related]  

  • 31. Neurocutaneous disorders: tuberous sclerosis, incontinentia pigmenti, and hypomelanosis of Ito.
    Wiss K
    Semin Neurol; 1992 Dec; 12(4):364-73. PubMed ID: 1485046
    [No Abstract]   [Full Text] [Related]  

  • 32. Dental defects in incontinentia pigmenti: case report.
    Himelhoch DA; Scott BJ; Olsen RA
    Pediatr Dent; 1987 Sep; 9(3):236-9. PubMed ID: 3333828
    [No Abstract]   [Full Text] [Related]  

  • 33. Intravitreal injection of ranibizumab in severe retinopathy of incontinentia pigmenti.
    Ni Y; Huang X; Ruan L; Xue K; Yu J; Peng J; Zhao P
    J AAPOS; 2018 Aug; 22(4):325-327.e3. PubMed ID: 29630932
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Dental disorders in incontinentia pigmenti. Apropos of a case].
    Favier-Payre A; Vincent R; Moulin G
    Actual Odontostomatol (Paris); 1987 Mar; 41(157):91-8. PubMed ID: 3475964
    [No Abstract]   [Full Text] [Related]  

  • 35. Structural Abnormalities of the Inner Macula in Incontinentia Pigmenti.
    Basilius J; Young MP; Michaelis TC; Hobbs R; Jenkins G; Hartnett ME
    JAMA Ophthalmol; 2015 Sep; 133(9):1067-72. PubMed ID: 26043102
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early indirect laser photocoagulation to induce regression of retinal vascular abnormalities in incontinentia pigmenti.
    Batioglu F; Ozmert E
    Acta Ophthalmol; 2010 Mar; 88(2):267-8. PubMed ID: 18983617
    [No Abstract]   [Full Text] [Related]  

  • 37. VARIABLE EXPRESSION OF RETINOPATHY IN A PEDIGREE OF PATIENTS WITH INCONTINENTIA PIGMENTI.
    Chen CJ; Han IC; Goldberg MF
    Retina; 2015 Dec; 35(12):2627-32. PubMed ID: 26035514
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of fluorescein angiography in incontinentia pigmenti: a case report.
    Tzu JH; Murdock J; Parke DW; Warman R; Hess DJ; Berrocal AM
    Ophthalmic Surg Lasers Imaging Retina; 2013; 44(1):91-3. PubMed ID: 23410815
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The blinding mechanisms of incontinentia pigmenti.
    Goldberg MF
    Trans Am Ophthalmol Soc; 1994; 92():167-76; discussion 176-9. PubMed ID: 7886862
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Incontinentia pigmenti. Apropos of a new case].
    Aubin F; Blanc D; Planchat A; Quencez E; Agache P
    Arch Fr Pediatr; 1987; 44(7):509-11. PubMed ID: 3426373
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.